WebOct 5, 2014 · Cisplatin (CAS No. 15663-27-1, MF-Cl 2 H 6 N 2 Pt; NCF-119875), ... Despite improved treatment options, including surgery, radiation and chemotherapy, HNSCC is associated with a high mortality rate. The overall 5-year survival rate of approximately 50% has not changed over the last decades. Cisplatin alone is not an effective drug in … WebJun 29, 2011 · Cisplatin is the most common agent used in combination with RT, and is one of the best studied. The standard regimen is three-weekly high-dose (100 mg/m 2) …
Cisplatin - The Penicillin of Cancer
WebSep 20, 2024 · Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer. WebCisplatin, given daily in combination with the radiotherapy described here to patients with nonmetastatic but inoperable non—small-cell lung cancer, improved rates of survival and control of... bioethics and palliative care division
Cisplatin Uses, Side Effects & Warnings - Drugs.com
WebCarboplatin + Docetaxel (Carboplatin + Taxotere®) is a Chemotherapy Regimen for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC) How does Carboplatin + Docetaxel work? Each of the medications in Carboplatin + Docetaxel are designed to slow the growth of and kill cancer cells. Goals of therapy: WebThe concomitant use of chemotherapy and radiation therapy has the theoretical advantage of radiosensitization with improved local control, preservation of the systemic effect of neoadjuvant treatment, and reduction in the total treatment time. WebApr 4, 2024 · A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol . 2006;79:34-38. 14. bioethics a primer for christians